GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Almirall SA (LTS:0O9B) » Definitions » Short Interest

Almirall (LTS:0O9B) Short Interest


View and export this data going back to 2010. Start your Free Trial

What is Almirall Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Almirall's Short Interest

For the Drug Manufacturers - Specialty & Generic subindustry, Almirall's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Almirall's Short Interest Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Almirall's Short Interest distribution charts can be found below:

* The bar in red indicates where Almirall's Short Interest falls into.


Almirall Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Almirall SA (LTS:0O9B) » Definitions » Short Interest
Comparable Companies
XMAD:FAE XMAD:RJF XMAD:LAB ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA XSWX:SDZ NSE:DIVISLAB HKSE:03692 SZSE:000538 NSE:TORNTPHARM VTRS BOM:500124 BOM:532321 NBIX BOM:543904
Traded in Other Exchanges
ALM:Spain E2Z:Germany
Address
Ronda General Mitre 151, Barcelona, ESP, 08022
Website
http://www.almirall.es
Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company's operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.

Almirall Headlines

No Headlines